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Abstract: Tumors frequently contain hypoxic regions that result from a shortage of oxygen due
to poorly organized tumor vasculature. Cancer cells in these areas are resistant to radiation- and
chemotherapy, limiting the treatment efficacy. Macrophages have inherent hypoxia-targeting
ability and hold great advantages for targeted delivery of anticancer therapeutics to cancer cells
in hypoxic areas. However, most anticancer drugs cannot be directly loaded into macrophages
because of their toxicity. In this work, we designed a novel drug delivery vehicle by hybridizing
macrophages with nanoparticles through cell surface modification. Nanoparticles immobilized
on the cell surface provide numerous new sites for anticancer drug loading, hence potentially
minimizing the toxic effect of anticancer drugs on the viability and hypoxia-targeting ability
of the macrophage vehicles. In particular, quantum dots and 5-(aminoacetamido) fluoresceinlabeled polyamidoamine dendrimer G4.5, both of which were coated with amine-derivatized
polyethylene glycol, were immobilized to the sodium periodate-treated surface of RAW264.7
macrophages through a transient Schiff base linkage. Further, a reducing agent, sodium cyanoborohydride, was applied to reduce Schiff bases to stable secondary amine linkages. The distribution
of nanoparticles on the cell surface was confirmed by fluorescence imaging, and it was found to
be dependent on the stability of the linkages coupling nanoparticles to the cell surface.
Keywords: anticancer drug, cellular vehicle, confocal microscopy, dendrimer, drug delivery,
hypoxia, nanotechnology
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The cell membrane, a semipermeable lipid bilayer, defines the cell boundary and
consists of lipids, proteins and carbohydrates that are responsible for selective uptake
of molecules, cell–cell interactions, cell–matrix interactions, and many other vital
cell activities. Because of the importance of cell surface interactions to cell and tissue
function, various cell surface engineering approaches have been explored to modify
the cell surface to manipulate cell behavior and function.1,2
Considerable progress has been made in introducing nonnative chemical species
to the cell membrane, permitting a wide range of applications in biology, medicine,
drug delivery, and tissue engineering.3 A molecule of interest can be attached to the cell
surface through a fatty tether including glycosyl-phosphatidylinositol (GPI)-anchored
proteins4 and cholesterol-tethered compounds.5 A viable alternative is to apply
enzyme-catalyzed chemical reactions to modify carbohydrates on the cell surface.
For example, existing surface glycoforms can be utilized as acceptors for reactions
with an exogenously applied glycosyltransferase and appropriate activated sugar
donor.1,6 Sialic acids are the most common terminal sugar residue on the cell surfaces
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and play an important role in cell adhesion and recognition.
Unnatural sialic acid precursors can be incorporated into
cell surface glycoforms by metabolic engineering.7 Direct
covalent reactions can also be applied to enable chemical
modification of cell surfaces.8,9 One possible approach is to
couple biomolecules of interest to the cell surface via reactive cell surface groups such as aldehydes and ketones.10,11
The generation of these reactive cell surface groups may be
achieved by direct chemical or enzymatic treatment, or by
the metabolic incorporation of an unnatural molecule that
contains the chosen chemical species.
Cell surface engineering has generated tremendous
advantages for drug delivery and tissue engineering. For
example, a synthetic adenovirus receptor inserted to the cell
surface via a metabolic engineering approach facilitates the
entrance of adenovirus into cells that are normally resistant to
infection by this virus.12 Uptake of exogenous proteins could
be enhanced by inserting appropriate synthetic receptors.13
Selectively killing tumor cells could be realized by controlling the targeting of an antibody through tagging tumor cells
with a non-natural sugar into the polysialic acid molecules
on the cell surface.14 Cell surface modification approaches
have also been applied to generate three-dimensional cell
aggregates or tissue-engineered constructs through cell crosslinking.15 A recent study reported that polyethylene glycol
(PEG) can be attached to the surface of islets to circumvent
immune rejection during transplantation of pancreatic islets
from donor to a patient.9
In this work, we designed a novel hypoxia-targeted drug
delivery vehicle by hybridizing macrophages with nanoparticles through cell surface modification. Tumors frequently
contain hypoxic regions that result from a shortage of oxygen
due to poorly organized tumor vasculature. Cancer cells in
these areas are resistant to radiation- and chemotherapy,
limiting the treatment efficacy.16 Macrophages and monocytes have inherent hypoxia-targeting ability and hold great
advantages for selective delivery of anticancer therapeutics to
cancer cells in hypoxic areas.16–19 However, most anticancer
drugs cannot be directly loaded into macrophages or monocytes because of their toxicity. Hybridizing a macrophage
or monocyte cellular vehicle with a synthetic carrier, particularly nanoparticles, may represent a novel approach for
effective delivery of anticancer drugs to hypoxic regions in
solid tumors. Immobilizing nanoparticles on the cell surface
provide numerous new sites for anticancer drug loading,
hence potentially minimizing the toxic effect of anticancer
drugs on the viability and hypoxia-targeting ability of the
macrophage or monocyte vehicles.
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The focus of the current work was to demonstrate the
feasibility of immobilizing nanoparticles including polyamidoamine (PAMAM) dendrimers and quantum dots (Qdots)
to the macrophage surface through cell surface chemical
modification. Dendrimers are highly branched macromolecules with low polydispersity and well-defined surface
functionality. Utility of dendrimers in this work allowed
us to take advantage of their versatility to explore optimal
approaches for cell-nanoparticle hybridization and realize a
high drug payload and assembly of multiple functional entities necessary for hybridization and drug delivery. Commercially available quantum dots coated with amine-derivatized
PEG was also studied for cell-nanoparticle hybridization.
Qdots have been explored for fluorescence imaging of living
cells.20 Although the limited number of surface groups of
Qdots is not advantageous for drug loading, hybridizing
cells with Qdots possessing long-term photostability offers a
noninvasive way for cell tracking in vivo and would provide
further evidence to demonstrate the feasibility of the cellnanoparticle hybridization approach explored in this work.

Experimental
Materials
Qdot® 525 ITK™ amino (PEG) quantum dots (simply referred
to as QD525) and 5-(aminoacetamido) fluorescein (AAF)
were purchased from Invitrogen (Carlsbad, CA). PAMAM
dendrimer G4.5 was purchased from Dendritech (Midland, MI).
PEG diamine (MW= ∼3350 g mol-1), N-hydroxysuccinimide
(NHS), 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide
hydrochloride (EDC), sodium cyanoborohydride (NaCNBH3),
sodium periodate (NaIO4), and sodium phosphate buffer
(10×) were purchased from Sigma-Aldrich (St. Louis, MO).
4',6-diamidino-2-phenylindole (DAPI), Dulbecco’s modified
Eagle medium (DMEM), sodium hydroxide, paraformaldehyde, phosphate-buffered saline (PBS), fetal bovine serum
(FBS), penicillin, and Trypan blue were purchased from Fisher
Scientific (Pittsburgh, PA).

Preparation of AAF-labeled PEGylated
G4.5 dendrimers (AAF-G4.5-PEG)
Synthesis

The synthesis of G4.5-PEG followed our previous work.21
Upon removal of methanol from G4.5 PAMAM stock solution by rotary evaporation, G4.5 PAMAM dendrimer (5 mg)
was dissolved in 2 mL of sodium PBS (0.1 M, pH = 5.5). To
this solution were added 5.4 mg of EDC and 3.2 mg of NHS.
After a 15 minute reaction at room temperature, 68.5 mg of
PEG diamine (MW = ∼3350 g mol-1) predissolved in the
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the cells were treated with 0.1 mM cold NaIO4 in 100 µL
of PBS (pH 7.4), incubated with shaking for 15 minutes at
4 °C in the dark, and then rinsed with cold PBS three times to
remove NaIO4.15 Following the NaIO4 treatment, the cells were
incubated with 12 µg of nanoparticles dissolved in 100 µL of
PBS for 0–24 hours. The resultant macrophage–T-nanoparticle
hybrids were washed with PBS and incubated in PBS.
At predetermined time points, macrophage–T-nanoparticle
hybrids were fixed with 300 µL of 4% paraformaldehyde for
fluorescence or confocal imaging. Untreated macrophages
incubated with nanoparticles were used as a control.

buffer solution was added to the reaction solution dropwise.
Subsequently, 1.4 mg of AAF predissolved in the buffer was
slowly added to the reaction solution. The reaction mixture
solution was stirred in the dark overnight. The resultant
AAF-G4.5-PEG nanoparticles were purified by dialysis and
then freeze dried.

Proton nuclear magnetic resonance (1H-NMR)
spectroscopy
The 1H-NMR spectra of dendrimer derivatives were recorded
on a Varian Mercury-300 MHz NMR spectrometer (Varian,
Palo Alto, CA). The solvent used was deuterium water (D2O),
which has a chemical shift of 4.8 ppm.

Macrophage–nanoparticle hybrids with a stable
linkage (macrophage–S-nanoparticle hybrids)

Fluorescence spectroscopy

Macrophage–T-nanoparticle hybrids were further treated with
100 µL of 0.1 mM NaCNBH3 for 1∼2 hours to convert the
transient Schiff base linkages to stable amide linkages, washed
with PBS, and incubated in PBS. At predetermined time
points, macrophage–T-nanoparticle hybrids were fixed with
4% paraformaldehyde for imaging. Untreated macrophages
incubated with nanoparticles were used as a control.

Fluorescence emission spectra of AAF and AAF-G4.5-PEG
in water were recorded on a Varian Cary Eclipse fluorescence
spectrophotometer with an excitation wavelength of 488 nm.

Preparation of macrophage–nanoparticle
hybrid vehicles
As illustrated in Scheme 1, nanoparticles (QD525 or AAFG4.5-PEG) were coupled to the surface of macrophages via
either a transient Schiff base linkage or a stable secondary
amine linkage.

pH-dependent cell viability assay
Since RAW264.7 macrophages were subjected to surface
modification and the rate of the stablizing amide reaction is
pH-dependent, the effect of pH of modifying solutions on
the RAW264.7 macrophage viability was studied. In brief,
RAW264.7 macrophages were initially incubated for two hours
in media at different pH values, including DMEM (pH 7.4,
control) and PBS (pH 8, pH 9 and pH 10, adjusted with sodium

Macrophage–nanoparticle hybrids with a transient
linkage (macrophage–T-nanoparticle hybrids)
RAW264.7 macrophages were plated on coverslips at a
density of 1.2 × 104 cells/coverslip. At 70% confluence,
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Scheme 1 Hybridization of nanoparticles and macrophage through cell surface modification. Sialic acid residues on the cell surface are modified with sodium periodate
to generate aldehydes. Aldehydes react with amine group of PEG conjugated to the nanoparticle surface to form Schiff bases. Schiff bases can be further reduced to stable
secondary amine linkages using sodium cyanoborohydride.
Abbreviation: PEG, polyethylene glycol.
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hydroxide), washed with PBS (pH 7.4) three times, and grown
in DMEM supplemented with 10% FBS and 5% penicillin for
48 hours. Viable cells were counted by using the Trypan blue
assay. In addition, toxicity of 0.1 mM NaCNBH3 in DMEM at
pH 7.4 was also evaluated. Cell viability was then determined
as follows: Cell viability (%) = total number of viable cells in
each group/total number of viable cells in the control ×100.

Fluorescence image analysis
True-color fluorescence images of macrophage–nanoparticle
hybrids were taken under a Zeiss Axiovert 200 inverted
fluorescence microscope (Carl Zeiss AG, Oberkochen,
Germany) or a Leica TCS-SP2 AOBS confocal laser scanning
microscope (Lecia, Solms, Germany). DAPI nuclear stain
was applied for colocalization of nanoparticles. Images were
analyzed with ImageJ software (National Institutes of Health,
Bethseda, MD).

Results and discussion
Preparation of macrophage–nanoparticle
hybrids
In this study commercial QD525 coated with an aminederivatized PEG layer and synthesized PEGylated carboxyl
terminated PAMAM dendrimer G4.5 were employed for
hybridization with macrophages. PEGylated PAMAM dendrimer G4.5 was labeled with AAF to allow confirmation of
immobilization of nanoparticles on the cell surface by fluorescence imaging. Polyanionic PAMAM dendrimer G4.5 has a
relatively high number of surface groups, negligible toxicity and
immunogenicity, and favorable biodistribution.22 The negatively
charged dendrimers have negligible cellular uptake due to their
low non-specific interaction with the negatively charged cell
surface. Inclusion of PEG provides dendrimers with favorable
pharmacokinetic and tissue distribution and reduces potential
accumulated toxicity and immunogenicity of the nanoparticles.
Importantly, PEG helps nanoparticles to escape from phagocytosis of macrophages. This is a critical step for constructing
the proposed hybrid delivery system. PEGylated dendrimers of
larger molecular weight and with more branches tend to have a
lower accumulation in cells as demonstrated previously.23
Similarly to the QD525 employed in this study, PEGylated
G4.5 was designed to have amine-derivatized PEG chains
on the surface, based on which cell surface modification
chemistry was explored. PEGylated dendrimers have
been well characterized previously.21,24–27 According to the
1
H-NMR measurement, an average of eight PEG chains
were coupled to G4.5. PEGylated G4.5 was labeled with a
moderately water-soluble fluorescence probe, AAF. As shown
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in Figure 1, AAF coupled to the dendrimer has an emission
wavelength of 515 nm, which is identical to the emission
wavelength of free AAF. The unaltered emission wavelength
of AAF following this coupling strategy was also found in
a previous report.28 Furthermore, the fluorescence emission
intensity of AAF coupled to PEGylated G4.5 is significantly
higher than that of AAF prepared in water at saturation,
suggesting that AAF coupled to PEGylated G4.5 has higher
water solubility than its unmodified form. The increase in
the water solubility of AAF was attributed to the successful
conjugation of AAF to the PEGylated dendrimer.
A number of methods have been developed to enable the
chemical modification of cell surfaces. In this project, we
employed a simple and well-documented methodology to
immobilize nanoparticles to the macrophage cell surface. In
particular, sialic acid residues embedded on the cell surface
were converted to aldehydes with sodium periodate. Our
results showed that the toxicity of NaIO4 was negligible at the
concentration of 0.1 mM. This was supported by the work of
Ong and coworkers.15 Aldehydes reacte with primary amine
end groups of PEG on the nanoparticle surface to form Schiff
bases. Schiff base linkage is labile and can be cleaved in
aqueous solution by hydrolysis. Accordingly, the macrophage–
T-nanoparticle hybrids constructed are expected to readily
release nanoparticles through the cleavage of the transient
Schiff base linkages. We also applied a reducing agent
sodium cyanoborohydride to reduce Schiff bases to stable
secondary amine linkages.29 It has been reported that sodium
cyanoborohydride has high specificity toward the Schiff base.
According to our cell viability studies (Figure 2), sodium
cyanoborohydride at 0.1 mM was nontoxic to RAW264.7
macrophages. As the reaction proceeds more efficiently at
basic pH,30 the viability of RAW264.7 macrophages at high pH
(8–10) was evaluated to determine whether the immobilization
chemistry can be performed at high pH. As shown in Figure 2,
pH affects the cell viability. The viability of RAW264.7 macrophages remains intact at pH 8 or pH 7.4 with 0.1 mM sodium
cyanoborohydride. The cell viability dropped slightly to 88%
at pH 9. By contrast, the viability was reduced drastically to
52% at pH 10. The results suggest that mild basic pH has a
minimal impact on the viability of RAW264.7 macrophages
and the optimum pH within that range can be explored for
increasing the immobilization efficiency.

Fluorescence image analysis
of macrophage–Qdot hybrids
Fluorescence microcopy and confocal microscopy were
applied to confirm the hybridization of nanoparticles
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Figure 2 pH-dependent viability of RAW264.7 macrophages. Cells were incubated for two hours at the indicated pH, and then assessed by the Trypan blue assay 48 hours
later. Nontoxicity of 0.1 mM sodium cyanoborohydride in DMEM at pH 7.4 was confirmed.
Note: Bar = SD.
Abbreviations: DMEM, Dulbecco’s modified Eagle’s medium; SD, standard deviation.
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with macrophages. As shown in Figure 3, both
macrophage–T-nanoparticle hybrids and macrophage–
S-nanoparticle hybrids prepared with QD525 exhibit strong
fluorescence intensity at the edge of the cells, clearly outlining the cell surface. Qualitatively, more QD525 were taken
up in macrophage–T-nanoparticle hybrids as opposed to
macrophage–S-nanoparticle hybrids, reflecting the stability

of the linkage between the nanoparticles and the cell.
Confocal microscopy images in z-sections were taken to
further examine the distribution of QD525 over the course
of time. Without cell surface modification, QD525 were
phagocytosed quickly and evenly distributed in the cytoplasm
(Figure 4A – 4 h and 14 h). Although QD525 were still internalized, a significant amount of QD525 accumulated at the

A

10 µm

B

10 µm

Figure 3 Fluorescence microscopy images of macrophage–Qdot hybrids. A) Macrophage–T-Qdot: macrophages treated with sodium periodate, incubated with QD525 for
four hours, and fixed; B) Macrophage–S-Qdot: macrophages treated with sodium periodate, incubated with QD525 for four hours, treated with sodium cyanoborohydride,
and fixed.
Notes: Original magnification, ×400; scale bar, 10 µm.
Abbreviation: Qdot, quantum dot.
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4h

14 h

A

B

C

20 µm
Figure 4 Confocal microscopy images of macrophage–Qdot hybrids at four hours (left panel) or 14 hours (right panel) post-treatment. A) QD525 incubated with untreated
macrophages (control); B) Macrophage–T-Qdot hybrids; C) Macrophage–S-Qdot hybrids.
Notes: Original magnification, ×630.
Abbreviation: Qdot, quantum dot.
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edge of the cells treated with sodium periodate (Figure 4B)
or a combination of sodium periodate and sodium cyanoborohydride (Figure 4C). QD525 immobilized on the cell surface
through a stable secondary amine bond displayed good stability overnight (Figure 4C – 14 h). In contrast, QD525 linked
to the cell surface via Schiff base linkages were found to be
re-distributed in the cell overnight (Figure 4B – 14 h).

A

Fluorescence image analysis
of macrophage–dendrimer hybrids
Macrophages hybridized with AAF-labeled PEGylated
PAMAM dendrimer G4.5 were also studied. As shown in
Figure 5A, the level of the internalization of AAF-G4.5-PEG
by untreated macrophages is low. This confirmed that
cationic surface charges and PEGylation indeed helped
to reduce nonspecific internalization by macrophages.
Further, an apparently biased distribution of AAF-G4.5-PEG
nanoparticles was observed on the surface of macrophages
that were treated with sodium perioate (Figure 5B) or the
combination of sodium periodate and sodium cyanoborohydride (Figure 5C). A significant increase in fluorescence intensity of macrophage–T-dendrimer hybrids and
macrophage–S-dendrimer hybrids as compared to the control
suggests that more dendrimer nanoparticles have been immobilized to the cell surface and/or internalized by the cells. The
amine linkages connecting dendrimers to the cell enabled
macrophage–S-dendrimer hybrids to carry dendrimers
stably on the surface for an extended period of time. We also
observed that when the surface-treated macrophages were
incubated with the same amount of AAF-G4.5-PEG (12 µg),
a condition of a high concentration (12 µg/100 µL) and a
short incubation (one minute) was relatively equivalent to a
condition of a low concentration (12 µg/1.5 mL) and a long
incubation (10 minutes) in terms of hybridization efficiency
as determined by confocal image analysis. Cell viability
remained good during the surface treatment.
To further evaluate the intracellular localization of
nanoparticles, we performed a colocalization assay on
AAF-G4.5-PEG with nuclear DAPI staining. Clearly shown
in Figure 6A, a significant amount of AAF-G4.5-PEG
nanoparticles were internalized within one-minute incubation and accumulated evenly in the cytoplasma with no
selectivity towards the cell surface after overnight culture.
Entry of the nanoparticles into nuclei was also observed
in the macrophages. This became more evident when the
cells were incubated with AAF-G4.5-PEG for an extended
period of time (overnight incubation, Figure 6B). In addition,
more nanoparticles were internalized by the cells following
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B

C

20 µm
Figure 5 Confocal microscopy images of macrophage–dendrimer hybrids.
A) Untreated macrophages incubated with AAF-G4.5-PEG for 10 minutes and
fixed immediately (control); B) Macrophage–T-dendrimer hybrids fixed immediately
following 10-minute incubation with AAF-G4.5-PEG; C) Macrophage–S-dendrimer
hybrids fixed at 14 hours following treatment of sodium cyanoborohydride. Original
magnification, ×630.
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Figure 6 Colocalization assay of AAF-G4.5-PEG (green) with nuclei (blue) by confocal microscopy. A) Control 1: untreated macrophages incubated with AAF-G4.5-PEG for
one minute, washed and cultured overnight (24 hours), then fixed and counterstained with DAPI; B) Control 2: untreated macrophages incubated with AAF-G4.5-PEG overnight (24 hours), then fixed and counterstained with DAPI; C) Macrophage–T-dendrimer hybrids: sodium periodate-treated macrophages incubated with AAF-G4.5-PEG for
one minute, cultured overnight (24 hours), then fixed and counterstained with DAPI; D) Macrophage–S-dendrimer hybrids: sodium periodate-treated macrophages incubated
with AAF-G4.5-PEG for one minute, treated with sodium cyanoborohydride, cultured overnight (24 hours), then fixed and counterstained with DAPI.
Notes: Original magnification, ×630.
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the overnight incubation as indicated by the increase in the
fluorescence intensity. Macrophage–S-dendrimer hybrids
(Figure 6D) show a stronger fluorescence intensity at the
cell surface and less in nuclei as compared to macrophage–
T-dendrimer hybrids (Figure 6C), confirming that the stability
of immobilized dendrimers in macrophage–S-dendrimer
hybrids was higher than macrophage–T-dendrimer hybrids.
It is apparent that fluorescently labeled nanoparticles
were taken into the macrophages after each treatment.
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Qualitatively, there is a uniform distribution of fluorescence
throughout the untreated control groups, suggesting cellular uptake pathways are responsible for this occurrence.
Following surface modification, a pronounced ring of fluorescence is observed towards the cell surface. Quantitative
analysis of the distribution of nanoparticle fluorescence was
attempted with the intensity profile generated by ImageJ
software (Figure 7). Since all confocal images were taken
under identical image acquisition settings, the fluorescence
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Figure 7 Quantitative analysis of the distribution of fluorescence intensity in representative cells. A) Control 1; B) Control 2; C) Macrophage–T-dendrimer hybrid;
D) Macrophage–S-dendrimer hybrid. The treatment conditions are detailed in Figure 6.
Notes: Original magnification, ×630.
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intensity profiles generated allowed us to quantitatively
analyze fluorescence distribution in individual cells based
on their relative fluorescence intensity. For each group, three
representative cells were chosen and analyzed. Individual
cells were measured three times from different orientations
with each orientation approximately bisecting midlines. From
each profile, intensity values were recorded from fluorescence
peaks at the two cell boundaries and from a fluorescence peak
near the midline of each trace. The results are summarized in
Table 1. The results from the intensity traces show that for a
nanoparticle incubation of one minute, there is 20.8% more
fluorescence at the cell boundaries versus the cell center. For
an overnight incubation, there was an even distribution of fluorescent intensity where the cell walls exhibited a fluorescence
value that was 99.8% of the fluorescence of the midpoint of
the slice. Surface modification drastically increased the ratio
of fluorescence between the cell walls versus the cell interior.
The macrophage–T-nanoparticle hybrids showed an 85.2%
increase in fluorescence near the cell exterior, whereas the
macrophage–S-nanoparticle hybrids showed a 94.4% increase
in cell wall fluorescence. Based on these measurements we
show that there is markedly more fluorescence near the cell
surface for surface-treated groups, whereas there is an even
distribution of nanoparticles in the control groups.
From a chemistry perspective, this work demonstrated
the proof-of-principle of chemically hybridizing macrophages with nanoparticles through cell surface modification.
The reaction conditions explored in this study were mild to
the cells. It should be noted that internalization of nanoparticles by macrophages seems to be an inevitable process
because of their innate phagocytic capability. Nonetheless,
our studies disclosed that cell surface modification provides
a means to retard the internalization progress and alter the
intracellular distribution of nanoparticles. A comprehensive
understanding of the trafficking and dynamic distribution
Table 1 Summary of the distribution of AAF fluorescence intensity in macrophages subjected to various treatments as indicated
below
Group

[L]

[I]

[R]

([L] + [R])/[I] (%)

A

70.3 ± 12.5

55.0 ± 3.7

62.6 ± 7.3

120.8

B

58.4 ± 10.6

57.8 ± 13.5

57.0 ± 6.4

99.8

C

64.3 ± 10.2

33.4 ± 8.7

59.3 ± 12.5

185.2

D

67.5 ± 8.1

33.6 ± 5.2

63.2 ± 6.1

194.4

(A) Control 1; (B) Control 2; (C) Macrophage–T-dendrimer hybrid; (D) Macrophage–
S-dendrimer hybrid (The treatment conditions are detailed in Figure 6). [L], average
fluorescence intensity at the left cell wall; [I] average fluorescence intensity at the
interior of the cell; [R], average fluorescence intensity at the right cell wall. The original
images (n = 3) were analyzed with ImageJ.
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of nanoparticles is needed in order for us to optimize the
hybridization process. Reducing nonspecific phagocytic
internalization of nanoparticles will be pursued in our laboratory. The sizes of the Qdots and PAMAM dendrimers as
an important factor affecting nanoparticle internalization by
cells will be studied. PAMAM dendrimers have a versatile
structure ideal for construction of drug delivery systems
and have been extensively studied by many groups including us.31–34 Future work will include hybridization of drugcarrying dendrimers and/or QD525 with macrophages and
studying the delivery efficiency of such a new drug vehicle
in terms of drug distribution in hypoxic areas using in vitro
spheroid models and animal models.

Conclusions
QD525 and dendrimers were immobilized to the macrophage
cell surface through either a transient Schiff base linkage
or a stable amine linkage. The distribution of nanoparticles
on the cell surface was confirmed by fluorescence imaging
and was found to be dependent on the stability of the linkages connecting nanoparticles to the cell surface. Achieving
homogeneous distribution of anticancer drugs within tumors
remains one of the major challenges in cancer chemotherapy
and is critical for treatment effectiveness. The current study
has explored an innovative way of utilizing nanoparticles and
cellular vehicles for anticancer drug delivery. Development
of a cell–nanoparticle hybrid vehicle through cell surface
modification would utilize the best aspects of both cellular
carriers and nanoparticles and may help to improve anticancer
drug distribution and penetration in tumors.
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